Company · Healthtech & Bio

Bitsphi

bitsphi.com ↗ ·Madrid ·Seed

Bitsphi (Bitsphi Diagnosis) is a Madrid-based neurotechnology startup developing EEG-based diagnostic tools that use brain connectivity patterns and machine learning to aid clinicians in diagnosing ADHD, with plans to expand into other cognitive and mental health conditions. Founded in 2021 out of collaboration with the Cognitive and Computational Neuroscience Laboratory (UCM), it runs clinical trials with Madrid hospital networks and holds Spain's "PYME Innovadora" certification. Backed by Bullnet Capital and CDTI's Innvierte program, with EU NextGenerationEU support.

Founded

2021

Founders

News

Rounds

Investors

SectorsNeurotechnology, Healthtech, Medical Diagnostics, Machine Learning Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Profile updated 31 Jul 2026

Founders

Álvaro López-Medrano

Founder and CEO

Global models 5

BrainCo

China · brainco.tech ↗

EEG/brain-computer-interface neurotech company building brain-signal-reading devices for health and cognitive applications, similar hardware+ML neurodiagnostic model.

$500M+Comparable

Akili Interactive

United States · www.akiliinteractive.com ↗

VC-backed neurotech company that built clinically validated, FDA-cleared digital tools specifically for diagnosing and treating ADHD, the closest indication match to Bitsphi.

$220MComparable

Mindstrong Health

United States · mindstrong.com ↗

Used digital biomarkers and machine learning to assess cognitive/mental health function, paralleling Bitsphi's signal-to-ML diagnostic pipeline.

$160MComparable

Kernel

United States · kernel.com ↗

Non-invasive brain-measurement hardware company applying neuroscience data and analytics to health applications, similar EEG-adjacent brain-signal diagnostics model.

$158MComparable

Cognoa

United States · cognoa.com ↗

AI/ML-driven diagnostic aid for a specific neurodevelopmental condition (autism) built for clinical use, directly analogous to Bitsphi's ADHD diagnostic model.

$54MComparable

Investors 2

Funding rounds

No announced rounds on record.

News & media

No coverage on record yet.